Cleared Traditional

K072662 - CHEETAH RELIANT, CHEETAH ACTIVE

K072662 is an FDA 510(k) clearance for CHEETAH RELIANT, manufactured by Cheetah Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DSB cleared through the Traditional 510(k) pathway after a 117-day FDA review.

K072662 · Cheetah Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2008
Decision
117d
Days
Class 2
Risk

K072662 is an FDA 510(k) clearance for the CHEETAH RELIANT, CHEETAH ACTIVE. Classified as Plethysmograph, Impedance (product code DSB), Class II - Special Controls.

Submitted by Cheetah Medical, Inc. (Mizpe Aviv, M.P. Misgav, IL). The FDA issued a Cleared decision on January 16, 2008 after a review of 117 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2770 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K072662

510(k) Number K072662 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 2007
Decision Date January 16, 2008
Days to Decision 117 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d faster than avg
Panel avg: 125d · This submission: 117d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DSB Device Classification - Class 2, Special Controls

Product Code DSB Plethysmograph, Impedance
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSB Plethysmograph, Impedance

All 81
Devices cleared under the same product code (DSB) and FDA review panel - the closest regulatory comparables to K072662.
AESCULON C2, AESCULON CHF CLINIC C2, AESCULON HYPERTENSION CLINIC C2 AND AESCULON PACEMAKER CLINIC C2
K081035 · Osypka Medical, Inc. · May 2008
PHYSIOFLOW SYSTEM
K060387 · Vasocom, Inc. · Apr 2008
AESCULON CHF, HYPERTENSION & PACEMAKER CLINIC
K070985 · Osypka Medical, Inc. · Feb 2008
BIOZ DX HEMODYNAMIC MONITOR WITH PHILIPS 12-LEAD ECG, MODEL 5100
K070156 · Cardiodynamics International Corp. · Sep 2007
BIOIMPEDANCE CARDIAC ANALYZING MEASURING SYSTEM, MODEL NICAS 2004 SLIM
K070500 · Ni Medical · Jul 2007
BIOZDX HEMODYNAMIC MONITOR AND 12-LEAD ECG
K051228 · Cardiodynamics International Corp. · Jun 2005
K072662 · CHEETAH RELIANT, CHEETAH ACTIVE
Download PDF FDA Summary Cheetah Medical, Inc.